This project is aimed at developing practical, safe and effective means of preventing the progression of liver disease in patients with chronic hepatitis C virus (HCV) infection. Approximately 800 patients with chronic hepatitis C who have failed to respond to therapy with alpha interferon (with or without ribavirin) and who have significant fibrosis on liver biopsy will be enrolled in a study of the efficacy and safety of a continuous long-term antiviral therapy (for as long as four years). The objective of the Trial is to evaluate whether continuous therapy with long-term antiviral therapy can slow the progression of liver disease, preventing cirrhosis or preventing worsening of cirrhosis, decompensation, development of hepatocellular carcinoma (HCC) and death from liver disease. The Trial will also evaluate the natural history of hepatitis C and the factors that predict or correlate with disease progression. The major focus will be to evaluate whether antiviral therapy, despite not leading to eradication of HCV, can suppress hepatocellular injury, necrosis and fibrosis. Patients with chronic hepatitis C who have previously been treated with alpha interferon without a sustained virological and biochemical response will be eligible to enter the Trial.

Project Start
1999-05-01
Project End
2007-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Burghardt, P R; Krolewski, D M; Dykhuis, K E et al. (2016) Nucleus accumbens cocaine-amphetamine regulated transcript mediates food intake during novelty conflict. Physiol Behav 158:76-84
Burghardt, Paul R; Rothberg, Amy E; Dykhuis, Kate E et al. (2015) Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans. J Clin Endocrinol Metab 100:3193-201
Robinson, Mike J F; Burghardt, Paul R; Patterson, Christa M et al. (2015) Individual Differences in Cue-Induced Motivation and Striatal Systems in Rats Susceptible to Diet-Induced Obesity. Neuropsychopharmacology 40:2113-23
Snow, Kristin K; Bell, Margaret C; Stoddard, Anne M et al. (2014) Processes to manage analyses and publications in a phase III multicenter randomized clinical trial. Trials 15:159
Wang, Weihua; Zhang, Xiaoan; Xu, Yanjuan et al. (2014) High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy. PLoS One 9:e100131
Everhart, James E; Wright, Elizabeth C (2013) Association of ?-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 57:1725-33
Morishima, Chihiro; Shiffman, Mitchell L; Dienstag, Jules L et al. (2012) Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C. Am J Gastroenterol 107:1388-98
Sterling, Richard K; Wright, Elizabeth C; Morgan, Timothy R et al. (2012) Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol 107:64-74
Everson, Gregory T; Shiffman, Mitchell L; Hoefs, John C et al. (2012) Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology 55:1019-29
Corey, Kathleen E; Zheng, Hui; Mendez-Navarro, Jorge et al. (2012) Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One 7:e27144

Showing the most recent 10 out of 67 publications